Post-hoc analysis of the FRAME study indicates that romosozumab is effective for osteoporosis, and safe, across most stages of renal disease.
Medscape Medical News …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
